BioAge Labs, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $9.0 | $0.0 | — | — |
| Operating income | -$92.8 | -$78.2 | -$48.4 | — |
| Net income | -$80.6 | -$71.1 | -$63.9 | — |
| Balance Sheet | ||||
| Total debt | $2.0 | $8.0 | — | — |
| Cash Flow Statement | ||||
| Free cash flow | -$82.3 | -$51.9 | -$37.5 | — |
Shares outstanding 45.9M · Free float 78.4%
Annual filing data through FY ended December 31, 2025; float as of October 3, 2026.